AURX insider buying and SEC filings, explained
Nuo Therapeutics, Inc. · CIK 1091596
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$300K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 27–28, 2026 | Purchase (code P) Amended filing | David Emerson Jorden (CEO and Director) bought 8,773 shares between Aug 27 and Aug 28 at about $1.09 ($10K), reported as a purchase (code P). Holdings up <1% to 2,070,000 shares. Not marked as a 10b5-1 plan trade. This amends an earlier filing that is not in our records. | SEC filing Filed Aug 31, 2026 |
| Nov 28, 2025 | Sale | David Emerson Jorden (CEO and Director) sold 200,000 shares at $1.50 ($300K). Holdings down 9% to 1,946,755 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 3, 2025 |
13 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AURX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.